Insurance Brokers

Marsh & Mclennan

Atria and CEO Reduce Stake in Marsh & McLennan Despite Strong Earnings and Dividend

Marsh & McLennan enters long-term partnership with Formula 1

Hillhouse Investment to Acquire Marsh’s Public Client Services

Goldman Sachs and Citigroup Upgrade Marsh & McLennan Stock to Buy

Cryder Capital Partners LLP Increases Holdings in Marsh & McLennan Companies, Inc.

Zacks Research Downgrades Marsh & McLennan's EPS Estimate

Truist Financial Corp Reduced Holdings in Marsh & McLennan Companies

Oliver Wyman Acquires CR3 Partners to Boost Restructuring Capabilities

Varma Mutual Pension Insurance Co Increased Its Holding in Marsh & McLennan Companies

Ashton Thomas Securities LLC Increases Holdings in Marsh & McLennan

Marsh McLennan Agency to Acquire TriBridge Partners

Marsh Risk to Launch Two New Risk Companion Tools at RIMS RISKWORLD

Marsh Risk Launches AI-Powered Risk Companion Analysis Suite

Insurers Require Ships to Follow Iran-Approved Routes Through Strait of Hormuz

Marsh & McLennan released FY2026 Q1 earnings on April 16 Pre-Market EST, actual revenue USD 7.597 B (forecast USD 7.398 B), actual EPS USD 2.36 (forecast USD 2.9881)

Marsh & McLennan Reports Q1 Earnings and Launches Efficiency Plan

MMC Reports Q1 Earnings: Revenue Down but Up 7.5%

Morgan Stanley Downgrades Marsh & McLennan's Target Price, Resulting in Stock Price Drop

Marsh & McLennan Companies' stock price falls after Mizuho Securities downgrades rating

Marsh's Mercer Completes PIP VIII Fundraising

Akanda

Agape ATP

Co-Diagnostics

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NewGenIvf

Tradr 2X Long QBTS Daily ETF

Tradr 2X Long RGTI Daily ETF

Defiance Daily Target 2X Long RGTI ETF

Liminatus Pharma

LAFAYETTE ACQUISITION CORP ORD USD0.0001(S/R)24/10/2030

MRSH

At its 2026 annual meeting on May 21, Marsh & McLennan stockholders re-elected all director nominees for one-year terms and ratified Deloitte & Touche as the independent registered public accounting firm for 2026.

PUBT

Marsh stockholders re-elect board at annual meeting

Marsh Stockholders Re-Elect Board of Directors During 2026 Meeting | MMC Stock News

StockTitan

Marsh Stockholders Re-Elect Board of Directors During 2026 Meeting | MMC Stock News

Marsh to Showcase the Power of Perspective at the Lenovo Grand Prix du Canada as Formula 1®’s Official Risk Partner and Official Insurance Brokering Partner | MMC Stock News

LENOVO GROUP

Lenovo Group

Liberty Media Corp-Liberty Formula One

Liberty Media Corp-Liberty Formula One - C

LENOVO GROUP-R

Marsh to Showcase the Power of Perspective at the Lenovo Grand Prix du Canada as Formula 1®’s Official Risk Partner and Official Insurance Brokering Partner | MMC Stock News

Marsh & Mclennan pre-market down 7.06%; CVD Equipment pre-market down 7.04%; Amesite pre-market up 229.47%; Meitu Technology pre-market up 99.54%; MetaVia pre-market up 71.17%

Price Alert

CVD Equipment

Amesite

Meiwu Tech

MetaVia

Pre-market hot trades in US stocks: Marsh & Mclennan pre-market down 7.06%; CVD Equipment pre-market down 7.04%

Marsh & McLennan Stock: Analyst Estimates & Ratings

Barchart Option

Marsh & McLennan Stock: Analyst Estimates & Ratings

Atria Investments Inc reduced its stake in Marsh & McLennan Companies, Inc. by 9.3% in Q4, holding 72,591 shares valued at $13.47 million. Other institutional investors also adjusted their positions. CEO John Q. Doyle sold 16,655 shares, decreasing his stake by 12.48%. Marsh & McLennan reported strong Q1 earnings, beating EPS estimates with a revenue increase of 7.6%. The company declared a quarterly dividend of $0.90 per share, with a yield of 2.3%. The stock is currently trading near its 12-month low.

Market Beat

Wells Fargo

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

Atria Investments Inc Has $13.47 Million Position in Marsh & McLennan Companies, Inc. $MRSH

Marsh & McLennan Companies (MRSH) is piloting Project Leapfrog, an AI risk strategy tool aimed at enhancing corporate risk management. Despite positive revenue growth, the stock has faced pressure, with a 30-day return down 8.3% and a year-to-date return down 12.79%. The current share price of $159.14 is below the fair value estimate of $203.10, suggesting it may be undervalued. However, concerns about AI disruption and high earnings multiples compared to peers raise questions about future growth potential. Investors are advised to consider the mixed signals before making decisions.

Simplywall

A Look At Marsh & McLennan (MRSH) Valuation As Project Leapfrog Showcases New AI Risk Capabilities

Marsh & McLennan Companies announced a multi-year partnership with Formula 1 as its Official Risk Partner and Official Insurance Brokering Partner, enhancing brand visibility. Concurrently, Oliver Wyman appointed AI-focused leaders to drive digital transformation. While these initiatives strengthen capabilities, they do not alleviate pressures from soft insurance pricing and moderating margins. The company projects $31.2 billion in revenue and $5.2 billion in earnings by 2029, with a fair value estimate of $203.10 per share, indicating a potential 24% upside from current prices. Investors should remain cautious of ongoing pricing challenges in the insurance sector.

Formula 1 Partnership and AI Push Could Be A Game Changer For Marsh & McLennan Companies (MRSH)

Marsh & McLennan has formed a multi-year global partnership with Formula 1, becoming its first Official Risk Partner and Insurance Brokering Partner. This collaboration aims to enhance brand visibility and client engagement, showcasing Marsh's risk expertise to corporate sponsors and teams. Despite mixed stock performance, the partnership is seen as a strategic move to open new opportunities in the competitive insurance market. Investors should monitor how this initiative translates into client wins and whether it integrates with Marsh's broader AI and data efforts.

Willis Towers Watson

Arthur J Gallagher

Marsh And McLennan’s Formula 1 Deal Puts Risk Story In Focus

Marsh & Mclennan(MRSH.US)

Marsh stockholders re-elect board at annual meeting

Marsh Stockholders Re-Elect Board of Directors During 2026 Meeting | MMC Stock News

Marsh to Showcase the Power of Perspective at the Lenovo Grand Prix du Canada as Formula 1®’s Official Risk Partner and Official Insurance Brokering Partner | MMC Stock News

Pre-market hot trades in US stocks: Marsh & Mclennan pre-market down 7.06%; CVD Equipment pre-market down 7.04%

Marsh & McLennan Stock: Analyst Estimates & Ratings

Atria Investments Inc Has $13.47 Million Position in Marsh & McLennan Companies, Inc. $MRSH

A Look At Marsh & McLennan (MRSH) Valuation As Project Leapfrog Showcases New AI Risk Capabilities

Formula 1 Partnership and AI Push Could Be A Game Changer For Marsh & McLennan Companies (MRSH)

Marsh And McLennan’s Formula 1 Deal Puts Risk Story In Focus